Xin Lang Cai Jing·2025-12-21 01:09Group 1: Institutional Research and Market Performance - A total of 165 listed companies disclosed institutional research records during the week of December 15-19, with approximately half achieving positive returns [1] - The stock with the highest increase from institutional research was Zhenyou Technology, which rose by 21.89%, while nine other companies, including Aerospace Intelligence and Hongmian Co., saw gains exceeding 10% [1] - Popular stocks included Chang'an Automobile, Yipin Hong, and Boying Special Welding, with Chang'an receiving the most institutional investors [1] Group 2: Chang'an Automobile's L3 Approval - Chang'an Automobile received approval for its L3-level conditional autonomous driving model, with 214 institutions participating in its research [2] - The approved model, Deep Blue SL03, will be tested in designated areas of Beijing and Chongqing [2] - Chang'an's L3 capability development began in 2017, with the application for approval submitted in November 2023 [3][4] Group 3: Safety and Commercialization of L3 Technology - The approved model is equipped with advanced 4D imaging millimeter-wave radar, which can replace laser radar under certain conditions [4] - Chang'an plans to limit the autonomous driving speed to 0-50 km/h based on user scenarios and safety considerations [5] - The company aims to complete safety verification and promote industry standards rather than pursuing the technical upper limit [5] Group 4: Boying Special Welding's Institutional Interest - Boying Special Welding hosted four institutional research sessions during the week, with 107 institutions participating [6] - The company focuses on special equipment manufacturing, particularly in anti-corrosion and anti-wear welding equipment for various industrial sectors [6] - Boying Special Welding has developed core technologies for high-frequency oscillation welding, addressing industry pain points in sectors like waste incineration and biomass power generation [6] Group 5: Yipin Hong's Share Sale - Yipin Hong conducted research with 119 institutions following its announcement to sell shares in Arthrosi [8] - Post-transaction, Yipin Hong will retain 100% rights to AR882 in China and priority rights for global production supply [8] - The transaction is expected to close in the first quarter of 2026 after U.S. antitrust approval [8]